VDPHL01 BID for alopecia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jul 2025: Trial started, NCT07146022
  2. 28 Aug 2025: Trial registered, NCT07146022

The trials

NCT07146022: Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

State
Under way
Phase
Phase 3
People
552 planned
Started
25 Jul 2025
Primary completion
Jun 2027
Arms
VDPHL01 BID
Results
None posted
  1. 25 Jul 2025: Trial started
  2. 28 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.